Switch to High-Dose Amoxicillin-Clavulanate
For sinusitis that has failed oral amoxicillin therapy, the next best antibiotic is high-dose amoxicillin-clavulanate (875-125 mg twice daily or 2 g twice daily for adults). This recommendation is based on the need to cover β-lactamase-producing organisms and penicillin-resistant Streptococcus pneumoniae that likely caused the treatment failure 1, 2.
Why Amoxicillin Fails
When amoxicillin alone doesn't work, you're dealing with one of two problems:
- β-lactamase-producing bacteria (Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus) that destroy amoxicillin before it can work
- Penicillin-resistant S. pneumoniae with altered penicillin-binding proteins
The addition of clavulanate inhibits β-lactamase enzymes, while the high dose overcomes resistant pneumococcus 2.
Dosing Specifics
Adults: Amoxicillin-clavulanate 875-125 mg twice daily for 10-14 days 1. For severe infection or high-risk patients, use 2 g twice daily 2.
Duration: Treat for 10-14 days, though some guidelines suggest continuing until symptom-free plus 7 days 1.
Alternative Options for Penicillin Allergy
If the patient has a true penicillin allergy (not just intolerance), your options are 2:
- Respiratory fluoroquinolones: Levofloxacin or moxifloxacin (preferred for non-type I hypersensitivity)
- Doxycycline: Reasonable alternative
- Cephalosporins: Cefuroxime, cefpodoxime, cefprozil, or cefdinir (for non-type I reactions only)
Important caveat: The 2020 EPOS data showed amoxicillin-clavulanate had faster symptom improvement (day 3-5) and lower relapse rates compared to cefuroxime 3, making cephalosporins a less optimal choice even when permitted.
When to Consider Broader Coverage
If the patient fails amoxicillin-clavulanate after 21-28 days, consider 1:
- Anaerobic coverage: Add clindamycin or metronidazole
- CT imaging: Rule out structural problems or complications
- Specialist referral: Consider ENT or allergy/immunology consultation
Common Pitfalls to Avoid
Don't use macrolides or trimethoprim-sulfamethoxazole as second-line agents for acute bacterial sinusitis—resistance rates exceed 40-50% for S. pneumoniae and H. influenzae 2
Don't assume chronic sinusitis has the same microbiology—if this patient had prior sinus surgery, the bacteria are different (S. aureus, Pseudomonas aeruginosa, E. coli), and culture-directed therapy with fluoroquinolones works better than empiric amoxicillin-clavulanate 4
Don't reflexively use fluoroquinolones first—while effective, they have comparable outcomes to amoxicillin-clavulanate but higher adverse event rates 2, and should be reserved for penicillin allergy or treatment failure
Watch for treatment failure indicators: No improvement within 3-5 days, worsening symptoms, high fever, or severe headache warrant reassessment 1
Evidence Quality Note
The 2025 AAO-HNS guideline 5, 6 now recommends "amoxicillin with or without clavulanate" as first-line therapy (a shift from 2015's amoxicillin-alone preference), acknowledging that treatment failure scenarios justify the broader coverage of amoxicillin-clavulanate from the start. The European guidelines 3 consistently show amoxicillin-clavulanate superiority in head-to-head trials, with significantly better early symptom resolution and lower relapse rates.